CorMedix Inc. (CRMD) Stock Profile — Insider Trades & Financials

Revenue$128.6M

Net Income$14.0M

EPS$1.97

Gross Margin83.4%

Market Cap$573.1M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Joseph Todisco

CEO & Executive Director

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Founded: 2006
Employees: 191
Headquarters: Parsippany, New Jersey, United States

⚡

Core Efficiency

ROE?

3.46%

ROA?

1.70%

D/E Ratio?

1.04

Op. Margin?

45.97%

📊

Profitability Ratios

Net Margin?

10.90%

Loading company sections...

CorMedix Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness